APTA — Aptamer Share News
0.000.00%
- £9.88m
- £5.70m
- £1.54m
New contract with top 10 pharma
Notice of Results, Analyst & Investor Presentation
Brief: Aptamer Announces New Contract With Global Pharma Company
Major top 3 global pharma contract win
Investor Event and Presentation
New contract with Metir plc
Notification of dealings by a director/PDMR
Therapeutic development agreement with Invizius
Biomarker Discovery Service Launch
AIM - AIM Notice - 22/08/2025
Update on licensing and development progress
Exercise of warrants
Holding(s) in Company
Contract extension with global pharma partner
Investor Technical Webinar
Holding(s) in Company
Holding(s) in Company
Investor Webinar
Trading Update